CLINICAL_TRIALS
trial_result
· 2021-11-17
Clinical Trial Update: A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis [Phase 3]
Summary
A completed Phase 3 trial evaluating the usability of a subcutaneous auto-injector for CT-P17 in patients with active rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celltrion | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-11-17